is being developed as the first whole genome, high throughput gene expression real-time PCR platform.
The opportunity to involve our SmartChip Real-Time PCR System in the development of a promising therapeutic agent such as Homspera is a significant achievement for WaferGen and one that we believe will provide immensely valuable validation for the SmartChip platform," stated Alnoor Shivji, WaferGen's chairman and chief executive officer.
We are very excited to be able to incorporate the WaferGen SmartChip technology into our studies at UT Southwestern," said Hal Siegel, Ph.
We are excited to work with Homspera and the SmartChip system, as we believe both possess the potential to play a key role in the development of innovative therapeutics in the area of wound healing.
In January 2009, WaferGen and UT Southwestern established a separate collaboration under which UT Southwestern is conducting novel research projects using the SmartChip Real-Time PCR System in order to identify and validate gene expression biomarkers related to wound healing.
The SmartChip Real-Time PCR System is designed as the first whole genome, high-throughput gene expression real-time PCR platform.
WaferGen believes the SmartChip Real-Time PCR System will be the first platform to combine the high-throughput capability and cost efficiencies of existing microarrays, with the sensitivity and accuracy of real-time PCR.
Establish SmartChip sales channel in the second half of 2009
Continued development of additional SmartChip assay panels
Such statements include statements relating to the company's goals, plans and projections, anticipated results of research, performance, reliability and cost-effectiveness of the company's SmartChip and other systems, and other statements that are not historical facts, including statements which may be preceded by the words "intends," "may," "will," "plans," "expects," "anticipates," "projects," "predicts," "estimates," "aims," "believes," "hopes," "potential" or similar words.
The Viisage iA-thenticate system facilitates the secure transfer of biometric identity information from the document to the border control systems while at the same time meeting all necessary standards to prevent unauthorized access to data on the smartchip.
Viisage will be demonstrating the capabilities of the iA-thenticate smartchip at the upcoming Biometrics Consortium event being held in Washington, DC from September 19 through September 21, and at the Biometrics 2005 event in London from October 20 through October 21.